|Security||CNAB / United Cannabis Corp. (909747107)|
|President and CEO||BLACKMON EARNEST|
|Industry||Cannabis and Medical Marijuana Dispensaries|
|Common Shares Outstanding||71,427,273 shares (as of 2018-06-30)|
Institutional Stock Ownership and Shareholders
United Cannabis Corp. (OTC:CNAB) has 0 institutional investors and shareholders that have
filed 13D/G or 13F forms with the Securities Exchange Commission (SEC).
Largest shareholders include
United Cannabis Corp. (OTC:CNAB) ownership structure shows current positions in the company by institutions and funds, as well as latest changes in position size. Major shareholders can include individual investors, mutual funds, hedge funds, or institutions. The Schedule 13D indicates that the investor holds more than 5% of the company and intends to actively pursue a change in business strategy. Schedule 13G indicates a passive investment of over 5%. Green rows indicate new positions. Red rows indicate closed positions. Click the link icon to see the full transaction history.
|PANAGORA ASSET MANAGEMENT INC||211||0||-100.00||0||0|
2017-11-25 - Asif
United Cannabis was originally formed on November 15, 2007 as a California corporation under the name MySkin, Inc. MySkin was engaged in the business of providing management services to a medical spa in Los Angeles, California which provided various advanced skin care services until March 31, 2014, when this business was sold to the former President of the Company. In early 2014 the company decided to exit the medical spa management business and change its focus to creating unique products which can be used to treat a wide range of diseases that can be used by patients globally. The company's products are subject to all existing marijuana laws in the United States. The company own intellectual property relating to the legalized growth, production, manufacture, marketing, management, utilization and distribution of medical and recreational marijuana and marijuana infused products. United Cannabis has entered into what the company believe are significant agreements with partners wh...
Related News Stories
Company To Report $2 Million In Revenue For The Third Quarter, Forecasting $10 Million For the Year
Company Is Initiating Activities To Establish Infrastructure For The Cultivation, Processing, Transportation and Research Of Cannabis
DENVER, CO / ACCESSWIRE / August 1, 2018 / United Cannabis Corporation (OTCQB: CNAB) (the "Company" or "United Cannabis") today announced that it has initiated clinical trials on its Prana Bio Nutrient Medicinals P1 Capsules for the treatment of chronic pain at Jamaica's University of the West Indies.
Company to Report $2 Million in Revenue for the Second Quarter, Up 1400% Over 2017, Forecasting $10 Million for the Year (0-1)
DENVER, CO / ACCESSWIRE / July 10, 2018 / United Cannabis Corporation (OTCQB: CNAB) (the "Company" or "United Cannabis") today announced that the South African Patent Office has declared effective the Company's patent application based upon PCT/US2015/056635, and pursuant to the Patent Cooperation Treaty (PCT), for "Cannabis Extracts and Methods of Preparing and Using Same."
as of ET